Both stocks may be worth considering for those looking to capitalize on the anti-obesity market.

Bristol Myers Squibb trades at a fraction of Eli Lilly's valuation while generating substantial free cash flow, but ...

Eli Lilly shares rise as Foundayo shows greater weight loss and A1C reduction than oral semaglutide in a new indirect ...

AbbVie leans on legacy income and portfolio transition, while Eli Lilly rides explosive growth in weight-loss drugs, but at ...

The top healthcare stock has been underperforming the market, and its returns haven't been as impressive as in recent years.

Fundamentals, not a stock split, will determine whether the bull case for Eli Lilly continues.

View Eli Lilly and Company LLY stock quote prices, financial information, real-time forecasts, and company news from CNN.

Eli Lilly (LLY) stock: new data shows Foundayo beats Novo Nordisk's Ozempic pill and Zepbound outperforms Wegovy HD in weight ...

As Novo works to turn itself around, some analysts say Lilly has advantages that could help it maintain its position at the ...

Eli Lilly & Co. shares on the NYSE are trading close to fresh 52-week highs after the company highlighted expanded U.S. insurance coverage for its obesity and diabetes drugs, keeping the U.S. pharma ...

Ken Langone, chairman and president of Invemed Associates and a co-founder of Home Depot (NYSE:HD | HD Price Prediction), used a CNBC Squawk Box appearance on September 22, 2026 to say that his Eli ...

Eli Lilly (LLY) is the Big Cap 20 component in focus this week, as the stock trades just below an entry point from a flat base. Investors should be on the lookout for a heavy volume move into the buy ...